iShares Genomics Immunology and Healthcare ETF (IDNA)
- Previous Close
24.15 - Open
24.20 - Bid 22.95 x 1200
- Ask 26.81 x 900
- Day's Range
24.22 - 24.61 - 52 Week Range
17.33 - 25.70 - Volume
23,160 - Avg. Volume
26,478 - Net Assets 140.07M
- NAV 24.57
- PE Ratio (TTM) 2.40
- Yield 1.14%
- YTD Daily Total Return 7.27%
- Beta (5Y Monthly) 1.13
- Expense Ratio (net) 0.47%
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. The index is composed of developed and emerging market companies that could benefit from the long-term growth and innovation in genomics, immunology and bioengineering. -null-.
iShares
Fund Family
Health
Fund Category
140.07M
Net Assets
2019-06-11
Inception Date
Performance Overview: IDNA
View MoreTrailing returns as of 10/11/2024. Category is Health.
People Also Watch
Holdings: IDNA
View MoreTop 10 Holdings (47.13% of Total Assets)
Sector Weightings
Related ETF News
View MoreResearch Reports: IDNA
View MoreKey Takeaways From Renewable Energy Conference
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
RatingPrice TargetLowering target price to $109.00
ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $109.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetLowering target price to $117.00
ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $117.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice TargetLowering target price to $123.00
ENPHASE ENERGY INC has an Investment Rating of HOLD; a target price of $123.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Low; a Growth Subrating of Medium; and a Value Subrating of High.
RatingPrice Target